Abstract
Evonik Industries’ nutrition and care business has struck a deal to manufacture, via fermentation, a mix of animal milk oligosaccharides developed by the start-up GNUbiotics. The companies say the product, AMObiome, can naturally restore the gut microbiota of cats, dogs, and livestock animals. In recent years, firms including BASF, DuPont, and Jennewein have commercialized human milk oligosaccharides for use in infant formula. In animals, the large sugar molecules can moderate infections from pathogens such as Escherichia coli and Salmonella, Evonik says.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
